Aperontrials
Cambridge, US · Founded 2026 · 1 known investors
Find your way into Aperontrials
Sign up to see every warm intro you have to Aperontrials
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aperontrials team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aperon builds a documentation layer for clinical trials, creating a continuous, auditable record of trial operations grounded in the study protocol. It serves trial sponsors seeking oversight of clinical trial execution.
Founders & leadership
JL
Joshua Louis MoscatoNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$505K disclosed across 1 round · 2026
▶$505KraisedAug 2026 · 7 investors · Other TechnologyRule 506(b)
▶$505KraisedAug 2026 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Joshua Louis MoscatoExecutive Officer, Director
- Amount sold
- $505K
- Proceeds to insiders
- $70K
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Aperontrials do?
- Aperon builds a documentation layer for clinical trials, creating a continuous, auditable record of trial operations grounded in the study protocol. It serves trial sponsors seeking oversight of clinical trial execution.
- Who are Aperontrials's investors?
- Aperontrials's investors include Stone Mountain Ventures.
- How much funding has Aperontrials raised?
- Aperontrials has disclosed $505K raised across 1 round.
- Where is Aperontrials headquartered?
- Aperontrials is headquartered in Cambridge, US.